Bone Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Bone Cancer, including details on symptoms, types, treatment.

Volume 5 (2008), Issue 4 (April)

1. Laparoscopic bowel resection in the setting of metastatic colorectal cancer.
   Ann Surg Oncol, 15(5): 1424-8. [Abstract] [Full-text]
2. A novel lung cancer signature mediates metastatic bone colonization by a dual mechanism.
   Cancer Res, 68(7): 2275-85. [Abstract] [Full-text]
3. Replacement of the hip in children with a tumor in the proximal part of the femur.
   J Bone Joint Surg Am, 90(4): 785-95. [Abstract] [Full-text]
4. Multimodality treatment of osteosarcoma: radiation in a high-risk cohort.
   Pediatr Blood Cancer, 50(5): 976-82. [Abstract] [Full-text]
5. Cultural adaptation, translation and validation of a functional outcome questionnaire (TESS) to Portuguese with application to patients with lower extremity osteosarcoma.
   Pediatr Blood Cancer, 50(5): 1039-42. [Abstract] [Full-text]
6. Bone mineral density deficits in pediatric patients treated for sarcoma.
   Pediatr Blood Cancer, 50(5): 1032-8. [Abstract] [Full-text]
7. Altered Stra13 and Dec2 circadian gene expression in hypoxic cells.
   Biochem Biophys Res Commun, 369(4): 1184-9. [Abstract] [Full-text]
8. Current surgical management of bone metastases in the extremities and pelvis.
   Semin Oncol, 35(2): 118-28. [Abstract] [Full-text]
9. The role of surgery in the management of metastatic spinal tumors.
   Semin Oncol, 35(2): 108-17. [Abstract] [Full-text]
10. Vascular management in rotationplasty.
    Clin Orthop Relat Res, 466(5): 1210-6. [Abstract] [Full-text]
11. Pulmonary nodules discovered during the initial evaluation of pediatric patients with bone and soft-tissue sarcoma.
    Pediatr Blood Cancer, 50(6): 1147-53. [Abstract] [Full-text]
12. The Memorial Sloan Kettering Cancer Center experience with outpatient administration of high dose methotrexate with leucovorin rescue.
    Pediatr Blood Cancer, 50(6): 1176-80. [Abstract] [Full-text]
13. Fungal infection by Paracoccidioides brasiliensis mimicking bone tumor.
    Pediatr Blood Cancer, 50(6): 1284-6. [Abstract] [Full-text]
14. Transfer of complex frontline anticancer therapy to a developing country: the St. Jude osteosarcoma experience in Chile.
    Pediatr Blood Cancer, 50(6): 1143-6. [Abstract] [Full-text]
15. Brain-sparing radiotherapy for neuroblastoma skull metastases.
    Pediatr Blood Cancer, 50(6): 1163-8. [Abstract] [Full-text]
16. Targeting the receptor activator of nuclear factor-kappaB (RANK) ligand in prostate cancer bone metastases.
    BJU Int, 101(9): 1071-5. [Abstract] [Full-text]
17. Ewing sarcoma: prognostic criteria, outcomes and future treatment.
    Expert Rev Anticancer Ther, 8(4): 617-24. [Abstract] [Full-text]
18. International collaborative study on ghost cell odontogenic tumours: calcifying cystic odontogenic tumour, dentinogenic ghost cell tumour and ghost cell odontogenic carcinoma.
    J Oral Pathol Med, 37(5): 302-8. [Abstract] [Full-text]
19. Alterations of FHIT and P53 genes in keratocystic odontogenic tumor, dentigerous and radicular cyst.
    J Oral Pathol Med, 37(5): 294-301. [Abstract] [Full-text]
20. Perlecan-rich epithelial linings as a background of proliferative potentials of keratocystic odontogenic tumor.
    J Oral Pathol Med, 37(5): 287-93. [Abstract] [Full-text]
21. Comparative study of fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for the detection of spinal bone marrow infiltration in untreated patients with multiple myeloma.
    Acta Radiol, 49(4): 427-35. [Abstract] [Full-text]
22. A 7th nerve palsy in a child with Langerhans histiocytosis.
    Orbit, 27(2): 123-5. [Abstract] [Full-text]
23. Treatment of intraorbital lesions using the Accuray CyberKnife system.
    Orbit, 27(2): 97-105. [Abstract] [Full-text]
24. Immunohistochemical evaluation of giant cell tumors of the jaws using CD34 density analysis.
    J Oral Maxillofac Surg, 66(5): 928-33. [Abstract] [Full-text]
25. Primary diffuse large B-cell lymphoma of bone displays preferential rearrangements of the c-MYC or BCL2 gene.
    Am J Clin Pathol, 129(5): 723-6. [Abstract] [Full-text]
26. CT-guided biopsy of bone: a radiologist's perspective.
    AJR Am J Roentgenol, 190(5): W283-9. [Abstract] [Full-text]
27. Labeling, characterization, and in vivo localization of a new 90Y-based phosphonate chelate 2,3-dicarboxypropane-1,1-diphosphonic acid for the treatment of bone metastases: Comparison with 99mTc-DPD complex.
    Bioorg Med Chem, 16(8): 4457-65. [Abstract] [Full-text]
28. RAD001 (Everolimus) inhibits growth of prostate cancer in the bone and the inhibitory effects are increased by combination with docetaxel and zoledronic acid.
    Prostate, 68(8): 861-71. [Abstract] [Full-text]
29. RANKL inhibition is an effective adjuvant for docetaxel in a prostate cancer bone metastases model.
    Prostate, 68(8): 820-9. [Abstract] [Full-text]
30. Peripheral ameloblastic fibroma of the maxilla: report of a case and review of the literature.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 105(5): e46-8. [Abstract] [Full-text]
31. Capecitabine and vinorelbine as first-line treatment in elderly patients (> or =65 years) with metastatic breast cancer. A phase II trial (SAKK 25/99).
    Oncology, 73(3): 228-37. [Abstract] [Full-text]
32. Phase II trial of pegylated liposomal doxorubicin-cyclophosphamide combination as first-line chemotherapy in older metastatic breast cancer patients.
    Oncology, 73(3): 210-4. [Abstract] [Full-text]
33. Phase I trial of the prostate-specific membrane antigen-directed immunoconjugate MLN2704 in patients with progressive metastatic castration-resistant prostate cancer.
    J Clin Oncol, 26(13): 2147-54. [Abstract] [Full-text]
34. FGF-8 is involved in bone metastasis of prostate cancer.
    Int J Cancer, 123(1): 22-31. [Abstract] [Full-text]

© 2004-2011 Bone Cancer Research Today. All Rights Reserved.